PeptidePedia The community reference

Talk:Blind sampling

Discussion page·3 threads·1 archive

The three conventions in the last section are applied on all twenty supplier articles. Changing them here without changing them there would leave the wiki describing a practice it does not follow.

This is the discussion page for the article Blind sampling. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Anonymous ordering: does it count as blinding?Resolved

Ordering under an unconnected name stops a supplier identifying the order. Is that blinding enough to describe as blind? GroupBuyGalen (talk) 11:21, 30 June 2025 (UTC)

No. It removes one of three failure modes and leaves the purchaser still choosing the vial and still choosing whether to submit the result. Calling it blind would make the word useless. BlindSampleBrid (talk) 14:55, 30 June 2025 (UTC)

Agreed. It is worth describing, precisely because people do it and think it settles the question. Describe it, name what it fixes, name what it does not. ChainCustodyChad (talk) 08:44, 1 July 2025 (UTC)

Written that way: the paragraph now names what anonymous ordering removes and what it leaves untouched. ✓ Resolved GroupBuyGalen (talk) 09:37, 2 July 2025 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.
This page was last edited on 2 July 2025, by GroupBuyGalen. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).